CFTR and cystic fibrosis: Furthermore, the ring finger and FYVE-like domain containing E3 ubiquitin-protein ligase (RFFL) influences the functionality of F508del CFTR by removing it from the cell surface, even in the presence of CF medications, thereby reducing drug efficacy (Fig. 5d).